Horst & Graben Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Horst & Graben Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$411K	Sell	800 -13	-2%	-$6.24K	0.05%	137
2026 Q1	$381K	Buy	813 +13	+2%	+$7.05K	0.05%	135
2025 Q4	$463K	Buy	800 +2	+0.3%	+$1.13K	0.07%	115
2025 Q3	$387K	Buy	798 +14	+2%	+$6.52K	0.06%	123
2025 Q2	$318K	Sell	784 -75	-9%	-$31.4K	0.05%	128
2025 Q1	$427K	Sell	859 -11	-1%	-$5.96K	0.08%	103
2024 Q4	$453K	Hold	870	–	–	0.08%	95
2024 Q3	$538K	Buy	870 +1	+0.1%	+$592	0.1%	85
2024 Q2	$481K	Hold	869	–	–	0.09%	86
2024 Q1	$505K	Hold	869	–	–	0.1%	85
2023 Q4	$461K	Buy	869 +1	+0.1%	+$484	0.1%	80
2023 Q3	$439K	Hold	868	–	–	0.11%	84
2023 Q2	$453K	Sell	868 -175	-17%	-$94.4K	0.11%	78
2023 Q1	$601K	Buy	1,043 +1	+0.1%	+$564	0.15%	65
2022 Q4	$574K	Buy	1,042 +1	+0.1%	+$530	0.15%	73
2022 Q3	$528K	Hold	1,041	–	–	0.15%	71
2022 Q2	$566K	Buy	1,041 +1	+0.1%	+$550	0.15%	71
2022 Q1	$614K	Hold	1,040	–	–	0.15%	67
2021 Q4	$694K	Buy	1,040 +1	+0.1%	+$624	0.17%	61
2021 Q3	$594K	Hold	1,039	–	–	0.16%	68
2021 Q2	$524K	Hold	1,039	–	–	0.15%	76
2021 Q1	$474K	Buy	1,039 +1	+0.1%	+$477	0.15%	83
2020 Q4	$484K	Hold	1,038	–	–	0.17%	72
2020 Q3	$458K	Buy	1,038 +1	+0.1%	+$413	0.18%	65
2020 Q2	$376K	Hold	1,037	–	–	0.17%	69
2020 Q1	$294K	Buy	+1,037	New	+$327K	0.15%	71

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Horst & Graben Wealth Management's TMO Position: Q2 2026 in Review

Horst & Graben Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 1.6% in Q2 2026, selling an estimated $6.24K and leaving 800 shares worth $411K. The position accounts for 0.05% of the portfolio, ranked #137.

Horst & Graben Wealth Management first reported a position in TMO in Q1 2020 and has held it in 26 quarters since. The position peaked at $694K in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Horst & Graben Wealth Management held 800 shares of Thermo Fisher Scientific worth $411K as of Q2 2026.
Horst & Graben Wealth Management sold 13 Thermo Fisher Scientific shares in Q2 2026, an estimated $6.24K.
Thermo Fisher Scientific made up 0.05% of Horst & Graben Wealth Management's portfolio in Q2 2026, its #137 holding.
Horst & Graben Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 26 quarters since.
Horst & Graben Wealth Management's Thermo Fisher Scientific position peaked at $694K in Q4 2021.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Horst & Graben Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.